Search Page

1

Cite

Share

Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatment.

Brüner M, Dige A, Loft AG, Laurberg TB, Agnholt JS, Clemmensen K, McInnes I, Lories R, Iversen L, Hjuler KF, Kragstrup TW. Brüner M, et al. Among authors: hjuler kf. Autoimmun Rev. 2021 Feb;20(2):102731. doi: 10.1016/j.autrev.2020.102731. Epub 2020 Dec 14. Autoimmun Rev. 2021. PMID: 33326852 Review.

Cite

Share

2

Cite

Share

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials.

Mease PJ, Helliwell PS, Hjuler KF, Raymond K, McInnes I. Mease PJ, et al. Among authors: hjuler kf. Ann Rheum Dis. 2021 Feb;80(2):185-193. doi: 10.1136/annrheumdis-2019-216835. Epub 2020 Oct 26. Ann Rheum Dis. 2021. PMID: 33106286 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

[Mountain medicine. II].

Bay B, Hjuler KF. Bay B, et al. Among authors: hjuler kf. Ugeskr Laeger. 2016 Oct 31;178(44):V05160368. Ugeskr Laeger. 2016. PMID: 27808057 Review. Danish.

Cite

Share

4

Cite

Share

Canakinumab for Atherosclerotic Disease.

Hjuler KF, Egeberg A. Hjuler KF, et al. N Engl J Med. 2018 Jan 11;378(2):197. doi: 10.1056/NEJMc1714635. N Engl J Med. 2018. PMID: 29322755 Free article. No abstract available.

Cite

Share

5

Cite

Share

[Mountain medicine - an introduction. I].

Hjuler KF, Bay B. Hjuler KF, et al. Ugeskr Laeger. 2016 Oct 31;178(44):V05160367. Ugeskr Laeger. 2016. PMID: 27808056 Review. Danish.

Cite

Share

6

Cite

Share

Localization of treatment-resistant areas in patients with psoriasis on biologics.

Hjuler KF, Iversen L, Rasmussen MK, Kofoed K, Skov L, Zachariae C. Hjuler KF, et al. Br J Dermatol. 2019 Aug;181(2):332-337. doi: 10.1111/bjd.17689. Epub 2019 May 7. Br J Dermatol. 2019. PMID: 30677133

Cite

Share

7

Cite

Share

General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach.

Thaçi D, de la Cueva P, Pink AE, Jalili A, Segaert S, Hjuler KF, Calzavara-Pinton P. Thaçi D, et al. Among authors: hjuler kf. BJGP Open. 2020 Dec 15;4(5):bjgpopen20X101108. doi: 10.3399/bjgpopen20X101108. Print 2020 Dec. BJGP Open. 2020. PMID: 33144365 Free PMC article.

Cite

Share

8

Cite

Share

Letter by Hjuler et al Regarding Article, "Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study".

Hjuler KF, Bøttcher M, Iversen L. Hjuler KF, et al. Circulation. 2018 Mar 6;137(10):1090-1091. doi: 10.1161/CIRCULATIONAHA.117.029784. Circulation. 2018. PMID: 29507002 No abstract available.

Cite

Share

9

Cite

Share

Systemic Inflammation and Evidence of a Cardio-splenic Axis in Patients with Psoriasis.

Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L. Hjuler KF, et al. Acta Derm Venereol. 2018 Apr 16;98(4):390-395. doi: 10.2340/00015555-2873. Acta Derm Venereol. 2018. PMID: 29327063 Free article.

Cite

Share

10

Cite

Share

Using FDG-PET/CT to Detect Vascular Inflammation in Patients with Psoriasis: Where to Look? And for What??

Hjuler KF, Gormsen LC, Iversen L. Hjuler KF, et al. J Invest Dermatol. 2017 Oct;137(10):2236-2237. doi: 10.1016/j.jid.2017.05.034. Epub 2017 Jun 23. J Invest Dermatol. 2017. PMID: 28652109 Free article. No abstract available.

Cite

Share